Insights On Clinical Technologies

  1. The Importance Of Reliable Data To Clinical Trial Activation 5/8/2025

    Find an easier way to identify and enroll eligible patients for your clinical trials with quality data and site selection.

  2. Measure Critical Health Outcomes In GLP-1 And Related Obesity Treatments 9/17/2024

    In this session of Digital Health Monthly, Dr. Glenn Gaesser shares his extensive research on the intersection of obesity and exercise physiology, emphasizing the importance of physical activity.

  3. One Easy Way To Reduce Data Errors And CRC Burnout 6/19/2024

    See how the implementation of cross-form logic can minimize data errors and alleviate burnout for clinical research coordinators handling complex trial data entry.

  4. Introducing Digitally-Enabled Biosample Consent Storage 6/13/2024

    Despite the rise of digital solutions in healthcare, paper consent forms are still common in today’s clinical trials. Unfortunately, these paper forms pose significant challenges in retaining the documentation of informed consent for centrally stored biospecimens.

  5. Why Portable 6-Lead Devices Are The Future Of Cardiac Monitoring 10/25/2024

    Explore advanced technologies that offer a remote solution to maintain rigorous standards for ECG assessment while adapting your trial to have a more patient-centered design.

  6. eCOA Best Practices For Crohn's And UC Trials 1/27/2025

    Around 200 trials annually use tools like the Crohn’s Disease Activity Index (CDAI) and Modified Mayo Score (mMS) to measure clinical remission. Implementing these in eCOA systems requires careful planning.

  7. Scientific Literature Reviews And AI's Potential For Evidence Synthesis 4/14/2025

    Scientific literature reviews are crucial for HEOR decision-making but notoriously slow. Explore how AI can potentially accelerate evidence synthesis while maintaining necessary scientific rigor.

  8. 2025 Safety And Regulatory Compliance Trends And Predictions 12/16/2024

    Explore the rapidly evolving regulatory landscape that pharmaceutical and biotech industries face as they integrate AI and advanced technologies into safety, compliance, and lifecycle management.

  9. Letter From The CEO: A New Era Of Drug Development Is Here 9/3/2024

    This letter from Medable CEO Michelle Longmire lays out why we created Studio, what it enables sponsors and CROs to do, and how it will help everyone bring more effective therapies to patients faster.

  10. New Data Sources Can Help Pharma Meet Challenges 6/19/2025

    Claire Riches, Citeline VP of Clinical Solutions, discussed the changing pharma landscape and data options, such as RWD, RWE, and AI at Citeline Elevate Spring 2025.